European Drug Prevention Prize, 2016

The Pompidou Group's European Drug Prevention Prize was first launched in 2004. It is awarded every two years. In each two-year cycle, up to three prizes are awarded. The 2016 Prize is the seventh cycle. Information about the 2014 prize winners issuite here. You can find information about earlier prize-winners by following the links in the 'Successful Projects' box on this webpage

Prize-winners are high-quality drug prevention projects that fully involve young people. Young people are involved in the development and implementation of activities, in project decisions, in project management and perhaps in project evaluation.

The Pompidou Group awards the Prize to highlight high-quality drug prevention projects that have proved successful in practice in involving young people. It aims to encourage the development of drug prevention work where young people are actively participating. The Pompidou Group believes that the genuine involvement of young people improves the possibilities of successful drug prevention.

The projects which apply are evaluated by a Jury of seven young people (aged between 16 and 21 at the time of their appointment) recruited from the Pompidou Group's and Council of Europe member States. The jurors are selected by the Pompidou Group based on their experience of youth participation in drug prevention. Jurors serve for two terms. In 2016, three of the jurors served for the 2014 Prize and four are new to the Jury. In 2016, the jurors come from France, Germany, Iceland, Israel, Morocco, Poland and Slovenia. The Jury is advised by a former juror and by a drug prevention expert, but only jury members take the decisions on awarding the Prize.

The prize-winners each receive a trophy, a diploma and a prize-money of €5.000. Previous prize-winners say that the recognition of their value by the Pompidou Group has been invaluable in helping them to secure funding.

Applications are sought from all member States of the Pompidou Group and of the Council of Europe as well as the MedNET countries. See the box below for the list of eligible countries.

Further details:
http://www.coe.int